Navigation Links
MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution
Date:10/7/2009

CARLSBAD, Calif., Oct. 7 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of a groundbreaking new product, LifeGuard Soil Preservation Solution, for microbial RNA stabilization in soil samples upon collection. LifeGuard solution will enable researchers to collect soil samples in remote locations without RNA degradation or changes in transcript levels during transport to the laboratory for microbial community analysis and metagenomics.

LifeGuard Soil Preservation Solution is the first product optimized specifically to protect microbial RNA in soil and sediment samples. Virtually all research on environmental samples involves sample collection in locations that are far from a laboratory. Without special handling, the RNA levels in these samples will be altered during transport resulting in unreliable data. LifeGuard Solution puts microbes into stasis immediately upon contact and keeps the sample stable at ambient temperature during transport, resulting in reliable data and enabling the analysis of microbial interactions via RNA.

LifeGuard Soil Preservation Solution is available now. For more information visit the MO BIO website (www.mobio.com) or call 800-606-6246 to order.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in Molecular Biology since 1993. A global leader in solutions for soil, water and microbial nucleic acid purification, MO BIO's Power® kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For samples that do not require inhibitor removal, MO BIO's UltraClean® line includes optimized products for DNA and RNA isolation from a variety of sample types. Also for clinical samples, the BiOstic(TM) kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.

SOURCE MO BIO Laboratories, Inc.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
2. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
3. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. Provide an Update on the Aclidinium Bromide Clinical Development Program
4. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
5. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
6. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
7. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
8. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
9. AMICAS Launches Major New Version of Radiology Information System at RBMA 2009
10. PARI Respiratory Launches PEP S
11. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
Breaking Medicine Technology:
(Date:8/21/2017)... CA (PRWEB) , ... August 21, 2017 , ... ... health services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar ... responders affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over ...
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with gluten intolerance ... you may be interested in participating in a research study that focuses on family ... understand more about the relational aspects of adults who have gluten sensitivities who cohabitate ...
(Date:8/19/2017)... ... August 19, 2017 , ... The digital health and ... with pending recognition status from the Centers for Disease Control and Prevention (“CDC”) ... and live video conferencing. , The DPP resulted from clinical work conducted ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners of America ... as an interventional pain management physician. He brings a wealth of pain management ... headaches, and significant experience in spinal cord stimulation for chronic pain. , Dr. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... a highly specialized asset-light logistics provider of complex transport solutions for mission-critical ... to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. ...
Breaking Medicine News(10 mins):